Axolbio/axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HOM/ax0320/1 Ea
细胞培养
商品编号
ax0320
品牌
Axolbio
公司
Axolbio
公司分类
Human Cells
1 Ea
商品信息
axolGEM iPSC-Derived Neural Stem Cells MAPT R406W HOM (1.5 million cells) and Neural Plating-XF Medium (30 mL)
Description:
Human iPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the R406W mutation (CGG>TGG) into the
MAPT
gene. This line is homozygous for the R406W mutation so both alleles contain the mutation. Click on the product images to see the data and further details.?
The R406W mutation in MAPT has been implicated in familial frontotemporal dementia and parkinsonism?(Hutton?
et al
., 1998; Behnam
et al
., 2015) and has been seen in patients with clinical presentation resembling Alzheimer's disease (Rademakers
et al
., 2003;?Lindquist
et al
., 2008). The R406W mutation reduces the
ABI
lity of MAPT/tau to bind to microtubules
in vitro
(Hong
et al
., 1998).?
Click here to see more data on Axol Neural Stem Cells
Product Specification:
Starting material
Dermal fibroblast
Donor gender
Female
Donor age at sampling
64 yrs
Karyotype
Normal
Reprogramming method
Episomal vector
Induction method
Monolayer & chemically defined medium
Genetic modification
Homozygous for the MAPT R406W mutation (CGG>TGG)
Genetic modification
Contains a puromycin resistance cassette (intronic)
Size
≥1.5 million cells
Kit components
1 vial of axolGEM Neural Stem Cells (≥1.5 million cells) and 1 bottle of Plating-XF Medium (30 mL)
Growth properties
Adherent
Shipping conditions
Dry ice
Storage conditions
Liquid nitrogen
产品货号:14236.0